Strengthening Solid Tumor Efficacy by Engineering TILs With Precision Genome Editing to Improve Recognition & Durability

  • Integrating targeted genetic edits to enhance tumor-specific antigen recognition
  • Reducing functional exhaustion to support sustained TIL persistence after infusion
  • Evaluating how multiplex engineering impacts response durability in solid tumors